Stocks · News reference
Nanox Imaging Ltd. announced new clinical data for its subsidiary Nanox.AI's aortic valve calcification (AVC) solution, presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Gainers Revolution Medicines (NASDAQ:RVMD) stock rose 14.1% to $227.83 during Wednesday's after-market session. The market value of their outstanding shares is at $41.6 billion. As per the news, the Q3 earnings
Entrepreneur and investor Moshe Moalem has disclosed an 8.49% beneficial ownership stake in Nano-X Imaging Ltd. and announced his opposition to a proposed increase in authorized shares.
Nano-X Imaging Ltd. disclosed that Chief Financial Officer Guy Nathansohn resigned from his position effective October 26, 2026, citing medical reasons.
Nano X Imaging (NASDAQ:NNOX) sees Q3 sales of $4.300 million-$4.400 million vs $5.453 million analyst estimate.